Healthcare / Medical Care FacilitiesHKSE
$18.51
-1.02 (-5.22%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $682.4M · quality 63.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
50/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.6B
P/E
11.7x
↓EV/EBITDA
5.0x
↓ROE
31.1%
↑Gross Margin
49.1%
↑Debt/Equity
1.27
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+22.4%
FCF CAGR
+56.9%
FCF margin
31.1%
FCF / Net income
2.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.00B · net income $317.6M · FCF $932.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.00B | $3.00B | $2.57B | $2.15B | $1.64B |
| Net Income | $317.6M | $317.6M | $228.5M | $215.7M | $103.1M |
| EBITDA | $887.0M | $887.0M | $728.0M | $644.8M | $452.4M |
| EPS | 1.37 | 1.37 | 0.99 | 0.94 | 0.45 |
| Gross Margin | 49.1% | 49.1% | 46.3% | 45.6% | 43.9% |
| Operating Margin | 15.0% | 15.0% | 12.0% | 12.4% | 8.0% |
| Net Margin | 10.6% | 10.6% | 8.9% | 10.1% | 6.3% |
| Balance Sheet | |||||
| Debt/Equity | 1.27 | 1.27 | 0.77 | 0.70 | 2.78 |
| Current Ratio | 0.98 | 0.98 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $932.0M | $932.0M | $682.4M | $466.3M | $241.2M |
| Returns | |||||
| ROE | 31.1% | 31.1% | 24.2% | 26.9% | 54.6% |
| Valuation | |||||
| P/E | 11.72 | 11.72 | 19.05 | 11.28 | — |
| EV/EBITDA | 5.05 | 5.05 | 6.33 | 4.31 | — |
| P/B | 4.20 | 4.20 | 4.59 | 3.04 | — |
| Growth & Yield | |||||
| Revenue Growth | 16.7% | 16.7% | 19.9% | 31.2% | — |
| EPS Growth | 38.4% | 38.4% | 5.3% | 110.2% | — |
| Dividend Yield | 3.9% | 3.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
6.2%
EPS terminal req.
$1.64
Spread vs growth
32.2%
5Y implied EPS CAGR
7.7%
EPS terminal req.
$1.99
Spread vs growth
30.7%
10Y implied EPS CAGR
8.9%
EPS terminal req.
$3.20
Spread vs growth
29.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.9%
Start / end P/E
18.9x → 13.5x
EPS bridge
0.99 → 1.37
Residual
-10.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.